Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW P DICKISON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1467794776
CMS profile
10799997
Location
HARTFORD, CT

General Payments · PY2022–2024

$906.84

  • Reported across 25 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$377.81

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $377.81 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $341.04 12
Janssen Pharmaceuticals, Inc $18.97 1
ITI, Inc. $17.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $186.32 3
PY2023 $342.71 8
PY2024 $377.81 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.80 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143429117 CMS
Janssen Pharmaceuticals, Inc $18.97 12/18/2024 Food and Beverage Undisputed 01/23/2026 1077949516 CMS
Teva Pharmaceuticals USA, Inc. $5.59 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151479874 CMS
Teva Pharmaceuticals USA, Inc. $13.67 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151479876 CMS
Teva Pharmaceuticals USA, Inc. $15.08 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151479894 CMS
Teva Pharmaceuticals USA, Inc. $114.57 02/22/2024 Food and Beverage Undisputed 01/23/2026 1151479914 CMS
Teva Pharmaceuticals USA, Inc. $6.79 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151479922 CMS
Teva Pharmaceuticals USA, Inc. $22.79 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151479924 CMS
Teva Pharmaceuticals USA, Inc. $3.18 10/24/2024 Food and Beverage Undisputed 01/23/2026 1151480028 CMS
Teva Pharmaceuticals USA, Inc. $13.04 10/24/2024 Food and Beverage Undisputed 01/23/2026 1151480030 CMS
Teva Pharmaceuticals USA, Inc. $8.63 11/04/2024 Food and Beverage Undisputed 01/23/2026 1151480032 CMS
Teva Pharmaceuticals USA, Inc. $125.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151480040 CMS
Teva Pharmaceuticals USA, Inc. $5.91 12/16/2024 Food and Beverage Undisputed 01/23/2026 1151480042 CMS
Teva Pharmaceuticals USA, Inc. $6.79 12/16/2024 Food and Beverage Undisputed 01/23/2026 1151480044 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.